Trend Direction
PHARMACEUTICAL PREPARATION MANUFACTURING increased from FY2025 to FY2026, moving from $2,532,943 to $1,177,657,773 in the ingested records.
- Latest: $1,177,657,773
- Previous: $2,532,943
NAICS 325412 includes $2,566,333,693 in federal contract obligations across 87 ingested award records.
PHARMACEUTICAL PREPARATION MANUFACTURING has $2,566,333,693 in ingested federal contract obligations across 87 award records in this naics profile.
Source: USAspending.gov. Last updated from ingested federal spending data: May 7, 2026.
PHARMACEUTICAL PREPARATION MANUFACTURING has $2,566,333,693 across 87 ingested award records, with the analysis below generated only from visible tables on this page.
PHARMACEUTICAL PREPARATION MANUFACTURING increased from FY2025 to FY2026, moving from $2,532,943 to $1,177,657,773 in the ingested records.
MCKESSON CORPORATION accounts for 45.9% of PHARMACEUTICAL PREPARATION MANUFACTURING's visible obligations in this slice, which is the first concentration signal to review before treating the market as broad or fragmented.
Department of Health and Human Services is the largest visible secondary category at $1,376,754,134. Use this alongside the relationship table to separate one-off award activity from repeat market exposure.
The latest displayed award is 36C24026K1006 from FY2026 with $1,175,683,451 in obligations. Recent rows help identify whether the profile is still active in current procurement data.
| FY202620 awards | $1,177,657,773 |
| FY202522 awards | $2,532,943 |
| FY202410 awards | $7,741,959 |
| FY20234 awards | $470,043 |
| FY20222 awards | $62,541 |
| FY202129 awards | $1,377,868,433 |
| MCKESSON CORPORATION17 awards | $1,177,370,615 |
| PHLOW CORP.1 awards | $696,665,954 |
| EMERGENT BIOSOLUTIONS CANADA INC2 awards | $678,720,348 |
| RLS (USA) INC.3 awards | $3,592,488 |
| ADVANCED ACCELERATOR APPLICATIONS USA INC5 awards | $2,203,543 |
| MEDI-PHYSICS, INC.2 awards | $1,907,351 |
| PROGENICS PHARMACEUTICALS INC2 awards | $1,191,408 |
| CARDINAL HEALTH 414, LLC5 awards | $948,688 |
| INO THERAPEUTICS LLC1 awards | $759,707 |
| CARDINAL HEALTH 108, LLC1 awards | $611,031 |
| Department of Health and Human Services21 awards | $1,376,754,134 |
| Department of Veterans Affairs26 awards | $1,187,818,683 |
| Department of Justice18 awards | $1,707,666 |
| Department of Defense21 awards | $43,030 |
| Department of Homeland Security1 awards | $10,181 |
| Award | Recipient | Fiscal year | Obligations | Date |
|---|---|---|---|---|
| 36C24026K1006 | MCKESSON CORPORATION | 2026 | $1,175,683,451 | Not available |
| 75A50120C00092 | PHLOW CORP. | 2021 | $696,665,954 | Not available |
| 75A50119C00037 | EMERGENT BIOSOLUTIONS CANADA INC | 2021 | $422,315,784 | Not available |
| 75A50119C00075 | EMERGENT BIOSOLUTIONS CANADA INC | 2021 | $256,404,564 | Not available |
| 36C24724C0063 | RLS (USA) INC. | 2024 | $2,317,816 | Not available |
| 36C25624N0975 | MEDI-PHYSICS, INC. | 2024 | $1,847,391 | Not available |
| 36C26124N0090 | ADVANCED ACCELERATOR APPLICATIONS USA INC | 2024 | $1,819,183 | Not available |
| 36C26224P0297 | RLS (USA) INC. | 2024 | $1,127,038 | Not available |
| 36C26325N0537 | CARDINAL HEALTH 414, LLC | 2025 | $761,645 | Not available |
| 36C25921F0086 | INO THERAPEUTICS LLC | 2021 | $759,707 | Not available |
PHARMACEUTICAL PREPARATION MANUFACTURING has $2,566,333,693 in ingested federal contract obligations across 87 award records in this naics profile.
PHARMACEUTICAL PREPARATION MANUFACTURING has $2,566,333,693 in ingested contract obligations across 87 award records.
MCKESSON CORPORATION is the largest listed relationship in this profile at $1,177,370,615.
Department of Health and Human Services is the largest listed secondary category at $1,376,754,134.
Source: USAspending.gov. Last updated from ingested federal spending data: May 7, 2026.